Pharmafile - Manufacturing and Production News
Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms which improve...
GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged...
Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety...
The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer and improve surgical...
Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against the Omicron coronavirus variant...
AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely...
Santhera Pharmaceuticals and ReveraGen BioPharma have announced new topline results after completion of the VISION-DMD study at week 48.
Contract development and manufacturing organisation Sterling Pharma Solutions has announced a £10m multi-year investment strategy for its site in...
Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for the...
The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins...